Intuitive Surgical shares declined by 1.2% in the latest session, underperforming the broader market which posted modest gains. Trading volume rose 15% above the 30-day average, signaling heightened investor interest. Analysts attribute the pullback to short-term profit-taking after the stock’s extended rally, while institutional investors trimmed positions by an estimated 2% over the past week, according to regulatory filings.

Over the past three months, Intuitive Surgical’s shares have climbed approximately 32%, narrowing the gap to within 4% of their all-time high. This surge reflects a robust 18% year-over-year increase in procedure volume, driven by strong demand in urology and gynecology. Utilization of installed systems has reached a record 65%, up from 58% a year earlier. Early commercial roll-out of the da Vinci 5 platform has exceeded management’s initial target by 20%, with 45 hospitals now actively using the new system, supporting projections for accelerating recurring revenue.